Beruflich Dokumente
Kultur Dokumente
Treatments
The Controversy
Controversy surrounds the increase in diagnosis of pediatric bipolar disorder.
This came to a peak in December of 2006, when a young girl diagnosed with
bipolar died of an overdose from three different medications after being
diagnosed with bipolar disorder and ADHD. This lead to a public outcry and
questions about the ethics of psychiatrists prescribing drugs to young
children (Parry & Allison, 2008). Psychiatrists often prescribe children with
bipolar disorder drugs used for adults, but there is little research on their
efficacy on children. These medications can have dangerous and permanent
side effects (Littrel & Lyons, 2010). Within the psychiatric community, there
has been controversy over methods of diagnosis, which are subjective and
inconsistent. There is no strict diagnostic criteria for pediatric bipolar
disorder, and children who fail to meet the criteria may even be diagnosed
with bipolar disorder not otherwise specified (BPD-NOS) (Sahling, 2009).
Others still argue that normal childhood behaviors are now seen as
symptoms for the disorder (Sahling, 2009).
Because of this controversy, large amounts of research have been published
on the disorder. Researchers have worked hard to improve the validity of
diagnosis using family backgrounds and structured interviews (Youngstrom et.
al, 2005; Algorta et al., 2013;). Research on screening tools finds that bipolar
children across several studies from different researchers show the same
abnormalities, meaning that despite the subjective nature of the diagnostic
criteria, clinicians can effectively and correctly diagnose children with
pediatric bipolar disorder (Youngstrom et. al, 2005).
Psychiatric Medications
The most common and controversial treatment for pediatric bipolar disorder
is psychiatric medication. These drugs have been given to adult patients for
years, but their efficacy on children has not been researched sufficiently
(Bradfield, 2010; Littrell & Lyons, 2010; Cosgrove et. al, 2013). The past few
years has seen an increase in studies done on drugs used to treat pediatric
bipolar disorder. Lithium, anticonvulsants, and atypical antipsychotics have
shown some efficacy in treatment of bipolar disorder (Smarty & Findling,
2007). Table 1 gives a brief overview of some of the research done on
psychiatric drugs.
Table 1
Average # of
participants
completing
study
Average
length of
studies
Average
response
rate
Lithium
49
4.7 weeks
55%
Anticonvuls
ants
29
6.6 weeks
66.25%
Atypical
antipsychoti
cs
38
4.7 weeks
70.95 %
The table above shows average number of participants, length of time, and
response rates from studies done on children and adolescents for drugs used to
treat bipolar disorder. One study on anticonvulsants was discontinued. Information
found from Smarty & Findling, 2007.
Alternative Treatments
For parents who want to avoid medication for as long as possible or
altogether, there are other options. There is evidence that behavior day
programs can decrease problematic behaviors to a normal childhood range
(McTate et. al, 2012). Programs that focus of teaching children routine, self
control, organization, and problem solving, as well as teaching families how
to deal with the child's outbursts have also shown promise (Bradfield 2010).
Finally, nutritional supplements may be a viable alternative, as nutrition has
been known to affect the functioning of the brain (Frazier et al., 2012).
Overall, treatments of all kinds must be researched more, and it is important
for parents to discuss all possible treatment options with their clinicians.
Works Cited
Algorta, G. P., Youngstrom, E. A., Phelps, J., Younstrom, J. K., Jenkins, M. M.
(2013). An
inexpensive family index of risk for mood issues improves identification
of pediatric
bipolar disorder. Psychological Assessment 25(1), 12-22.
doi:10.1037/a0029225
Bradfield, B. (2010). Bipolar Mood Disorder in children and adolescents: in
search of theoretic,
therapeutic and diagnostic clarity. South African Journal Of Psychology,
40(3), 241-249.
Carr, A. (2009). Bipolar disorder in young people: Description, assessment
and evidence-based
treatment. Developmental Neurorehabilitation,12(6), 427-441.
doi:10.3109/17518420903042454
Cosgrove, V. E., Roybal, D., Chang, K.D. (2013). Bipolar depression in
pediatric populations.
Pediatric Drugs 15(2), 83-91. doi:10.1007/s40272-013-002-8
Frazier, E. A., Fristad, M. A., & Arnold, L. (2012). Feasibility of a nutritional
supplement as
treatment for pediatric bipolar spectrum disorders. Journal of
Alternative &
Complementary Medicine, 18(7), 678-685. doi:10.1089/acm.2011.0270
Littrell, J., & Lyons, P. (2010). Pediatric Bipolar Disorder: An issue for Child
Welfare. Children
& Youth Services Review, 32(7), 965-973.
doi:10.1016/j.childyouth.2010.03.021
McTate, E. A., Badura Brack, A. S., Handal, P. J., & Burke, R. V. (2013). A
program
intervention for pediatric bipolar disorder: Preliminary results. Child &
Family
Behavior Therapy, 35(4), 279-292. doi:10.1080/07317107.2013.846194
Parry, P., & Allison, S. (2008). Pre-pubertal paediatric bipolar disorder: a
controversy from
America. Australasian Psychiatry, 16(2), 80-84.
doi:10.1080/10398560701829592
Sahling, D. L. (2009). Pediatric bipolar disorder: Underdiagnosed or fiction?.
Ethical Human
Psychology & Psychiatry, 11(3), 215-228. doi:10.1891/15594343.11.3.215
Smarty, S., & Findling, R. L. (2007). Psychopharmacology of pediatric bipolar
disorder: A
review. Psychopharmacology, 191(1), 39-54. doi:10.1007/s00213-0060569-y
Youngstrom, E. A., Findling, R. L., Kogos Youngstrom, J., & Calabrese, J. R.
(2005). Toward an
evidence-based assessment of pediatric bipolar disorder. Journal Of
Clinical Child &
Adolescent Psychology, 34(3), 433-448.
doi:10.1207/s15374424jccp3403_4